Learning modules and courses on AI law, AI governance, and related regulation.
State-of-play: medical AI, EU “AI gigafactories,” and evidence standards
UK funds AI studies to predict drug-interaction side effects. Government announced three MHRA projects, one using NHS data + AI to identify adverse effects from drug combinations before patient exposure. Compliance note: strengthens the case for auditable clinical-AI evidence and data-governance controls. Commission signs MoU with EIB & EIF on “AI gigafactories.” New EU initiative to support facilities combining >100k advanced AI processors with energy-efficient infrastructure for frontier-model training; expect procurement and sustainability obligations to feature heavily.